i-SENS, Inc. (KOSDAQ:099190)
South Korea · Delayed Price · Currency is KRW 16,790
-470 (-2.72%)
Oct 2, 2026, 3:30 PM KST
i-SENS Market Cap
i-SENS has a market cap or net worth of 482.82 billion as of October 1, 2026. Its market cap has decreased by -9.46% in one year.
Market Cap
482.82B
Enterprise Value
589.65B
Revenue
326.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,790.00
ChartMarket Cap Chart
Since January 30, 2013, i-SENS's market cap has increased from 232.76B to 482.82B, an increase of 107.43%. That is a compound annual growth rate of 5.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 482.82B | 9.99% |
| Dec 30, 2025 | 438.95B | 4.01% |
| Dec 30, 2024 | 422.03B | -46.36% |
| Dec 28, 2023 | 786.74B | 74.15% |
| Dec 29, 2022 | 451.77B | 9.85% |
| Dec 30, 2021 | 411.25B | 0.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SD Biosensor | 733.27B |
| InBody Co.,Ltd | 702.03B |
| BioNote | 471.77B |
| T&L Co., Ltd. | 441.59B |
| WON TECH | 429.24B |
| Sky Labs | 346.16B |
| Samyang Biopharm | 346.14B |
| Curexo | 336.27B |